Domača stran8QQ • FRA
add
AbCellera Biologics Inc
Prejšnji trg. dan.
1,78 €
Dnevni razpon
1,78 € - 1,78 €
Letni razpon
1,70 € - 3,79 €
Tržna kapitalizacija
588,01 mio. USD
Povprečni obseg
448,00
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
NASDAQ
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | mar. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 4,24 mio. | −57,45 % |
Stroški poslovanja | 24,40 mio. | −4,55 % |
Čisti dohodek | −45,62 mio. | −12,34 % |
Čista dobičkovnost prihodkov | −1,08 tis. | −164,04 % |
Earnings per share | −0,15 | −7,14 % |
EBITDA | −57,33 mio. | −14,54 % |
Efektivna davčna stopnja | 13,90 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | mar. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 605,27 mio. | −13,29 % |
Skupna sredstva | 1,34 mrd. | −8,13 % |
Skupne obveznosti | 321,23 mio. | −3,59 % |
Celoten lastniški kapital | 1,02 mrd. | — |
Shares outstanding | 298,48 mio. | — |
Razmerje P/B | 0,52 | — |
Donosnost sredstev | −11,58 % | — |
Donosnost kapitala | −14,16 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | mar. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −45,62 mio. | −12,34 % |
Denar iz dejavnosti | −11,55 mio. | 72,30 % |
Denar iz naložb | 7,94 mio. | −73,47 % |
Denar iz financiranja | 5,97 mio. | 110,88 % |
Neto sprememba denarnih sredstev | 2,94 mio. | 130,17 % |
Prost denarni tok | −63,60 mio. | −21,59 % |
Vizitka
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
Generalni direktor
Datum ustanovitve
2012
Sedež organizacije
Spletno mesto
Zaposleni
596
